Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Kansas City, Missouri 64111


Purpose:

The primary purpose of this study is to determine the best dose of tezacitabine when combined with oxaliplatin in patients with metastatic colorectal cancer. This study will also evaluate tumor response to the combination of anti-cancer drugs.


Criteria:

- Patients with metastatic colorectal adenocarcinoma who have failed one prior course of chemotherapy. - Patients must have at least one measurable tumor. - Patients may not have received prior treatment with oxaliplatin.


Study is Available At:


Original ID:

TEZ101


NCT ID:

NCT00051688


Secondary ID:


Study Acronym:


Brief Title:

Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer


Official Title:


Overall Status:

Terminated


Study Phase:

Phase 2


Genders:

Both


Minimum Age:

18 Years


Maximum Age:

N/A


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

Chiron Corporation


Oversight Authority:

United States: Food and Drug Administration


Reasons Why Stopped:


Study Type:

Interventional


Study Design:

Primary Purpose: Treatment


Number of Arms:

0


Number of Groups:

0


Total Enrollment:

0


Enrollment Type:


Study Dates

Start Date:June 2003
Completion Date:August 2004
Verification Date:July 2006
Last Changed Date:July 10, 2006
First Received Date:January 15, 2003

Study Outcomes

There are no available Study Outcomes

Study Interventions

Intervention Type:Drug
Name:tezacitabine
Intervention Type:Drug
Name:oxaliplatin

Study Arms

There are no available Study Arms

Study Agencies

Agency Class:Industry
Agency Type:Lead Sponsor
Agency Name:Chiron Corporation

Sample and Retention Information

There are no available Sample and Retention Information

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


This study is not currently recruiting Study Participants. The form below is not enabled.